News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99 Results
Type
Article (6)
Press Release (93)
Section
Business (13)
Deals (1)
Drug Development (17)
FDA (3)
News (34)
Policy (8)
Tag
Alliances (7)
Antibody-drug conjugate (ADC) (1)
Approvals (5)
Clinical research (23)
Collaboration (1)
COVID-19 (2)
C-suite (1)
Data (11)
Earnings (6)
Events (16)
Executive appointments (1)
FDA (7)
Government (1)
Healthcare (1)
Infectious disease (2)
IPO (1)
Neuropsychiatric disorders (1)
Neuroscience (14)
Non-profit (1)
People (10)
Phase 1 (1)
Phase 3 (22)
Pipeline (8)
Preclinical (1)
Regulatory (12)
Schizophrenia (14)
Date
Last 30 days (4)
Last 365 days (20)
2026 (16)
2025 (11)
2024 (15)
2023 (11)
2022 (10)
2021 (9)
2020 (14)
2019 (8)
2017 (2)
2016 (1)
2014 (1)
2011 (1)
Location
Asia (17)
California (1)
Europe (79)
Massachusetts (2)
New Jersey (11)
Northern California (1)
United States (14)
99 Results for "medincell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medincell’s Dr Grace Kim to Participate in Piper Sandler CNS Symposium
August 11, 2026
·
2 min read
Press Releases
Medincell Achieves Major Milestone with U.S. FDA Approval of WELTRUZA™ (olanzapine)
October 9, 2026
·
2 min read
Press Releases
Medincell to Participate in Upcoming September 2026 Investor Conferences
September 9, 2026
·
2 min read
Press Releases
Medincell Appoints Edna Venneker, MD, as Chief Medical Officer
September 1, 2026
·
2 min read
Press Releases
Medincell Announces New Publication Date for Its Half-Year Financial Result (April 1st – September 30, 2026)
October 15, 2026
·
2 min read
Press Releases
Medincell’s Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026
September 21, 2026
·
2 min read
Press Releases
Medincell Brings Total Non-Dilutive Financing Secured Since July 2026 to €41.8 Million with an Additional €13.8 Million Loan
October 14, 2026
·
1 min read
Press Releases
Medincell Reports FY 2025-26 Annual Results
June 17, 2026
·
2 min read
Press Releases
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth
November 11, 2025
·
2 min read
Press Releases
Medincell’s Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris®
September 23, 2024
·
2 min read
1 of 10
Next
